| 0.55 Data as of Jan 30 |  0.00 / 0.00%Today’s Change | 0.34 Today|||52-Week Range 0.90 | +17.27% Year-to-Date |
| Previous close | 0.55 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 0 |
| Market cap | $20.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +56.82% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +31.77% |
| P/E ratio | 0.7 |
| Price/Sales | 0.50 |
| Price/Book | 0.21 |
| Today’s change | Today’s % change | |
|---|---|---|
| ISRIsoRay Inc | +0.00 | +0.20% |
| TPITianyin Pharmaceutic... | +0.03 | +5.08% |
| IBIOIbio Inc | +0.01 | +2.50% |
| NUINNutrastar Internatio... | -0.01 | -1.00% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $72.7M |
| Annual profit (last year) | $25.9M |
| Net profit margin | 35.65% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Shaoming Li, MBA |
Chief Financial Officer Weiqiu David Dong |
Corporate headquarters Harbin, Heilongjiang |
.
